Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; Extranodal invasion is a significant risk factor for peritoneal metastasis

被引:4
|
作者
Tanaka, T [1 ]
Kumagai, K [1 ]
Shimizu, K [1 ]
Masuo, K [1 ]
Yamagata, K [1 ]
机构
[1] Showa Univ, Toyosu Hosp, Dept Surg, Koutou Ku, Tokyo 1358577, Japan
关键词
gastric cancer; peritoneal metastasis; lymphatic advancement; extranodal invasion;
D O I
10.1002/1096-9098(200011)75:3<165::AID-JSO3>3.0.CO;2-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: We investigated the relationship between peritoneal metastasis and lymphatic involvement in gastric cancer by examining resected specimens. Methods: Twenty-seven consecutive gastric cancer patients who had synchronous peritoneal metastasis and 29 who developed metachronous peritoneal metastasis after surgery between 1985 and 1997 were included in this study. They were compared with 61 advanced gastric cancer (pT2 or more deeply into the gastric wall in the UICC-TNM) patients who had neither synchronous nor subsequent peritoneal metastasis, and who lived a disease-free course during 3 years. We compared the patients' clinicopathological features and in particular, the patterns of extranodal invasion in the resected lymph nodes. Results: Extranodal invasion with peritoneal metastasis was more common than extranodal invasion without peritoneal metastasis (P < 0.0001). Multivariate analysis revealed that the correlation between extranodal invasion and peritoneal metastasis was highly significant (P < 0.0001); the odds ratio was 18.894. Metastasis to the lymph nodes was the next most significant risk for peritoneal metastasis (P = 0.0043). Conclusions: We believe that the lymphatic system correlates closely with the establishment of peritoneal metastasis. J. Surg. Oncol. 2000;75:165-171. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 50 条
  • [1] Liver metastasis in gastric cancer with particular reference to lymphatic advancement
    Kumagai K.
    Tanaka T.
    Yamagata K.
    Yokoyama N.
    Shimizu K.
    [J]. Gastric Cancer, 2001, 4 (3) : 150 - 155
  • [2] LYMPHATIC ADVANCEMENT TO PERITONEAL DISSEMINATION AND LIVER METASTASIS IN GASTRIC-CANCER PATIENTS
    MAEHARA, Y
    TOMISAKI, S
    ODA, S
    SAKAGUCHI, Y
    ICHIYOSHI, Y
    SUGIMACHI, K
    [J]. ANTICANCER RESEARCH, 1994, 14 (6B) : 2755 - 2757
  • [3] PREDICTORS OF PERITONEAL METASTASIS IN GASTRIC CANCER
    Harris, C.
    Ostwal, V.
    Goel, M.
    Bal, M.
    Shrikhande, S.
    [J]. GUT, 2015, 64 : A121 - A121
  • [4] Treatment of gastric cancer with peritoneal metastasis
    Feldbruegge, Linda
    Wolf, Vincent
    Gronau, Felix
    Oeff, Alan
    Alevizopoulos, Alexia-Eugenia
    Jara, Maximilian
    Rau, Beate
    [J]. ONKOLOGE, 2020, 26 (10): : 945 - 950
  • [5] Editorial: Peritoneal metastasis of gastric cancer
    Wang, Shuyi
    Song, Jialin
    Xiong, Bin
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Is the peritoneal lavage cytology coincided with peritoneal metastasis for gastric cancer?
    Wang, Wei
    Xiong, Wenjun
    Peng, Yaohui
    Li, Jin
    Huang, Haipeng
    Zheng, Yansheng
    Luo, Lijie
    Wan, Jin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Issues on peritoneal metastasis of gastric cancer: an update
    Wang, Zhen
    Chen, Jun-qiang
    Liu, Jin-lu
    Tian, Lei
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (01)
  • [8] Predictors of peritoneal metastasis in gastric cancer.
    Kaplieva, Irina V.
    Kit, Oleg I.
    Frantsiyants, Elena M.
    Gevorkyan, Yuriy A.
    Soldatkina, Natalya V.
    Samoylenko, Nikolay S.
    Kharabezov, Dmitry A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
    Daisuke Kobayashi
    Yasuhiro Kodera
    [J]. Gastric Cancer, 2017, 20 : 111 - 121
  • [10] Surgical treatment for gastric cancer with peritoneal metastasis
    Yamamura, Y
    Kodera, Y
    Kito, T
    [J]. PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 1049 - 1054